Brand Name:

Biovirapine ^®

Dosage:

200 mg

Generic Name:

Nevirapine

Pharmacotherapeutic Group:

Antiviral (systemic)

Therapeutic Indication:

Nevirapine: Biovirapine is indicated for use in combination with other antiretroviral agents for the treatment of HIV-1-infection.

Dosage and Administration:

one 200 mg tablet daily (4 mg/kg/day in pediatric patients) for the first 14 days (lead-in) followed by one 200 mg tablet twice daily (4 or 7 mg/kg twice daily, according to age, for pediatric patients).

Side Effects:

• Dermatologic:Rash (grade 1 and 2, 13.3%; grade 3 and 4, 1.5%)
• Gastrointestinal:Diarrhea (37% to 41% ), Nausea (20% to 38%)
• Neurologic: Fatigue, Headache